To date, apart from the findings in the top tertile of the NPC trial, which derive from a post-hoc analysis of a small trial, all the evidence linking Se or selenoprotein P to type-2 diabetes is cross-sectional. The gene discussed is SELENOP; the disease is type 2 diabetes mellitus.